Sign Up to like & get
recommendations!
0
Published in 2021 at "Pharmaceutical nanotechnology"
DOI: 10.2174/2211738510666211222113358
Abstract: BACKGROUND The desirable levels of lipids, especially in patients with coronary artery disease, might not be achievable with a single lipid-lowering drug; thus, combination therapy using atorvastatin and gemfibrozil seems to be a promising approach.…
read more here.
Keywords:
fe3o4;
hplc dad;
determination atorvastatin;
atorvastatin gemfibrozil ... See more keywords